Secnidazole formulations and use in treating bacterial vaginosis
US11253501B2 · kind B2 · utility
0Cited by
32References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2016 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Jun 1, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5377
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments described herein are directed to novel pharmaceutical compositions comprising a plurality of microgranules comprising nitroimidazole compounds, and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.